Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2015
At a glance
- Drugs Elamipretide (Primary)
- Indications Chronic heart failure; Myocardial infarction; Reperfusion injury
- Focus Pharmacokinetics
- Sponsors Stealth Peptides
- 22 Jan 2013 Results have been reported in a Stealth Peptides media release.
- 22 Jan 2013 Status changed from recruiting to completed based on information reported in a Stealth Peptides media release.
- 20 Dec 2012 Status changed from planning to recruiting according to ClinicalTrials.gov.